Market Overview:
The pressure ulcers treatment market is experiencing rapid growth, driven by aging population and rising chronic conditions, advancements in wound care technologies, and increased healthcare spending and infrastructure. According to IMARC Group's latest research publication, "Pressure Ulcers Treatment Market Size, Share, Trends and Forecast by Ulcer Type, Product Type, End User, and Region, 2025-2033", the global pressure ulcers treatment market size was valued at USD 5.54 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 8.25 Billion by 2033, exhibiting a CAGR of 4.30% from 2025-2033.
This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.
Download a sample PDF of this report: https://www.imarcgroup.com/pressure-ulcers-treatment-market/requestsample
Our report includes:
- Market Dynamics
- Market Trends and Market Outlook
- Competitive Analysis
- Industry Segmentation
- Strategic Recommendations
Growth Factors in the Pressure Ulcers Treatment Market
- Aging Population and Rising Chronic Conditions
The growing prevalence of the aging population around the world is a key component generating momentum in the pressure ulcers treatment market. Older adults are prone to developing pressure ulcers due to immobility, skin being thinner than other populations, and the effects of chronic diseases such as diabetes or cardiovascular disorders that negatively impacts healing. A recent study from 2023 at a nursing home in the United States found that more than 10% of residents aged 65 years and older had developed a pressure ulcer in the span of only one year. This increase in the aging population along with the increase in chronic illnesses creates a cycle, where increased demand is created for advanced wound care products such as hydrocolloid dressings and negative pressure wound therapy medical devices, for the treatment and prevention of pressure ulcers.
- Advancements in Wound Care Technologies
Technological improvements in wound care are a major growth driver for the treatment of pressure ulcers market. More sophisticated dressings (e.g., foam, alginate, etc.) and therapy innovations (e.g., bioengineered skin substitutes) to support improved healing and reduce pain. For example, a clinical trial conducted in Europe in 2024 found that smart dressings with sensors reduced time-to-heal by 20% by continuously assessing and displaying the condition of the wound in real time. Innovative wound care technologies are attracting healthcare providers who need to solve and manage problems faster with less effort. With increased adoption and the prospect of more innovations, additional research and development will be triggered to address some of the more complex pressure ulcer cases.
- Increased Healthcare Spending and Infrastructure
Growing healthcare expenditure and improved medical infrastructure globally propel the pressure ulcers treatment market. Governments and private sectors are investing in better hospital facilities, specialized wound care clinics, and training for healthcare professionals. In India, for instance, a 2024 government initiative expanded wound care training for nurses in rural hospitals, reducing pressure ulcer complications by 15%. Enhanced access to advanced treatment options and a focus on patient-centered care drive demand for high-quality products and services, fostering market growth as healthcare systems prioritize effective management of chronic wounds.
Key Trends in the Pressure Ulcers Treatment Market
- Shift Toward Preventive Care Strategies
A significant development affecting the pressure ulcers treatment market is the emphasis on preventative care. Examples include healthcare providers giving more attention and focus to early intervention through the use of pressure relieving devices and integrated solutions, including pressure redistributing mattresses and pressure relieving cushions. A recent case study conducted at a UK hospital in 2024 identified that after embedding pressure redistributing mattresses into the care pathway of bedridden patients, the incidence of ulceration in this patient cohort decreased by 25 %. This moving trend refocuses attention to proactive approaches in care settings like performing regular skin examinations, checking patients positioning, bolstering mitigation methods that collectively reduce costs of treatment without sacrificing outcomes, and, further, aligns with healthcare systems that are more engaged in reducing hospital acquired conditions and improved quality of life for their patients.
- Rise of Telemedicine and Remote Monitoring
The emergence of telemedicine and remote monitoring is revolutionizing the management of pressure ulcer occurrences. Telemedicine allows healthcare companies to monitor patients’ wounds digitally, removing certain barriers to access to care, mainly in underserved rural areas. In 2025, a pilot program was initiated in Australia to use telehealth to help home caregivers manage their patients' wounds and monitor healing progress. The program maintained the availability of vigilant follow-ups and demonstrated a 30% decrease in ulcer-related (complications), re-hospitalization rates. Wearable devices (e.g., smartwatches) and mobile applications that track skin health are becoming more common, enabling patients to respond early and avoid progression or worsening of their condition while transitioning care back to their primary healthcare provider or receiving care in their community. This is consistent with healthcare's transition to patient-centered, technology-enabled care delivery.
- Growing Adoption of Biologics and Regenerative Therapies
The use of biologics and regenerative therapies is an emerging trend in the pressure ulcers treatment market. Products like growth factor therapies and stem cell-based treatments promote faster tissue regeneration. A 2024 U.S. clinical study reported that platelet-rich plasma therapy accelerated healing in stage III ulcers by 35% compared to standard treatments. These therapies are gaining popularity due to their effectiveness in severe cases, encouraging pharmaceutical companies to invest in research and expand product portfolios, thus shaping the market toward innovative, biologically driven solutions for complex wound care.
Leading Companies Operating in the Pressure Ulcers Treatment Industry:
- 3M Company
- Arjo AB
- B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG)
- Cardinal Health Inc.
- Coloplast A/S
- Hill-Rom Holdings Inc. (Baxter International Inc.)
- Invacare Corporation
- Mölnlycke Health Care AB
- Smith & Nephew plc
- Span America (UTi Worldwide Inc.)
- Stiegelmeyer GmbH & Co. KG
- Stryker Corporation
Pressure Ulcers Treatment Market Report Segmentation:
By Ulcer Type:
- Stage 1
- Stage 2
- Stage 3
- Stage 4
Stage 4 pressure ulcers account for 39.8% of the market in 2024, driven by their severity and the increasing prevalence among immobile or chronically ill patients, particularly due to diabetes, obesity, and aging.
By Product Type:
- Wound-Care Dressings
- Wound-Care Devices
- Others
Wound-care dressings dominate the market with a 65.4% share in 2024, as they create optimal healing environments and prevent infections, particularly for chronic wounds requiring advanced moisture and temperature regulation.
By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Homecare Settings
Hospitals lead the market with 62.3% of the share in 2024, as they provide essential care for patients at high risk of pressure ulcers, utilizing advanced wound care technologies and preventative measures to improve outcomes.
Breakup By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
The pressure ulcers treatment market spans multiple regions, including North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa, each contributing to the overall landscape of pressure ulcer management.
Research Methodology:
The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145